You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2024

CLINICAL TRIALS PROFILE FOR PEFICITINIB


✉ Email this page to a colleague

« Back to Dashboard


Clinical Trials for Peficitinib

Trial ID Title Status Sponsor Phase Summary
NCT01096862 ↗ A Study to Explore Efficacy and Safety of ASP015K in Subjects With Moderate to Severe Psoriasis Completed Astellas Pharma Inc Phase 2 The purpose of this study is to explore the efficacy and safety of multiple, escalating doses of ASP015K when compared to placebo in subjects with moderate to severe plaque psoriasis.
NCT01225224 ↗ Single and Multiple Oral Administration Study of ASP015K in Healthy Nonelderly Volunteers Completed Astellas Pharma Inc Phase 1 A study to evaluate the safety, tolerability and PK profiles of single and multiple doses of ASP015K in healthy nonelderly men.
NCT01554696 ↗ A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Who Have Had an Inadequate Response to Methotrexate Completed Astellas Pharma Inc Phase 2 The purpose of this study is to evaluate the safety and efficacy of ASP015K in moderate to severe rheumatoid arthritis subjects who are methotrexate-inadequate responders (MTX-IR).
NCT01565655 ↗ A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Completed Astellas Pharma Global Development, Inc. Phase 2 The purpose of this study is to evaluate the safety and efficacy of ASP015K in moderate to severe rheumatoid arthritis (RA) subjects
>Trial ID >Title >Status >Phase >Summary

Clinical Trial Conditions for Peficitinib

Condition Name

Condition Name
Intervention Trials
Arthritis, Rheumatoid 5
Rheumatoid Arthritis 3
Healthy Volunteers 2
Pharmacokinetics of ASP015K 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH
Intervention Trials
Arthritis, Rheumatoid 9
Arthritis 9
Psoriasis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Peficitinib

Trials by Country

Trials by Country
Location Trials
Japan 97
United States 52
Mexico 5
Poland 4
Taiwan 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State
Location Trials
Alabama 5
Texas 4
Tennessee 4
Kentucky 4
Florida 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Peficitinib

Clinical Trial Phase

Clinical Trial Phase
Clinical Trial Phase Trials
Phase 3 4
Phase 2 5
Phase 1 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status
Clinical Trial Phase Trials
Completed 13
Active, not recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Peficitinib

Sponsor Name

Sponsor Name
Sponsor Trials
Astellas Pharma Inc 10
Astellas Pharma Global Development, Inc. 2
Astellas Pharma China, Inc. 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type
Sponsor Trials
Industry 15
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.